Cathie Wood, founder of Ark Invest, emphasized the underestimated potential of artificial intelligence in healthcare during a recent interview. According to PANews, Wood believes AI can revolutionize cancer diagnosis through blood tests before symptoms appear. She also noted that the pharmaceutical industry faces a $300 billion patent cliff over the next five years, presenting both challenges and opportunities.